Key Values & Strategies 

"Cambridge Biotics" has incorporated in the United Kingdom and aims to support and supply knowledge-based and innovation oriented initiates on practical and applicable themes of pharmaceutical industries in vision of networking in global markets and industrial formations. Given the importance and priorities to research key indicators in pharmaceutical sciences and industries, Cambridge Biotics walks in a road of disseminating, representing, re-evaluating and reforming the emerging markets and solutions without borders based on knowledge and innovation mappings.   

Cambridge Biotics has been registered in the United Kingdom, Registration Number: 11459980

Nature of Business (SIC Codes): 

  • Wholesale of pharmaceutical goods
  • Research and experimental development on biotechnology

Recognition and Membership

Directorial and Executive board of Cambridge Biotics have been appointed as the official members of UK Clinical Pharmacy Association (UKCPA) and Pharmaceutical & Healthcare Sciences Society (PHSS).

Innovation Cycle

Accelerating the "Definition" to "Delivery" is the fully innovative and integrated key strategy follows by Cambridge Biotics. Planning and implementing the strategy for achieving to this target is always following the main scope and vision of our company as a sustainable process of Research and Development in pharmaceutical industries. 

New approaches to linking the research outlines in medical pharmacy services to deliverable productions and solutions are initiating by Cambridge Biotics.

Oops! This site has expired.

If you are the site owner, please renew your premium subscription or contact support.